---
title: Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for People With Spinal Cord Injury
nct_id: NCT07519928
overall_status: RECRUITING
phase: NA
sponsor: University of British Columbia
study_type: INTERVENTIONAL
primary_condition: Spinal Cord Injuries (SCI)
countries: Canada
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT07519928.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07519928"
ct_last_update_post_date: 2026-04-15
last_seen_at: "2026-05-12T07:17:41.485Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for People With Spinal Cord Injury

**NCT ID:** [NCT07519928](https://clinicaltrials.gov/study/NCT07519928)

## Key Facts

- **Status:** RECRUITING
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 50
- **Lead Sponsor:** University of British Columbia
- **Collaborators:** Canadian Institutes of Health Research (CIHR)
- **Conditions:** Spinal Cord Injuries (SCI)
- **Start Date:** 2026-04-01
- **Completion Date:** 2028-03-31
- **CT.gov Last Update:** 2026-04-15

## Brief Summary

The goal of this clinical study is to determine the feasibility and explore the potential benefits of pelvic floor muscle training during inpatient SCI rehabilitation on urinary, bowel, and sexual function and quality of life in people with SCI. The main questions it aims to answer are:

1. What is the feasibility of recruiting inpatients from SCI rehabilitation to a pelvic floor muscle training program?
2. What is the feasibility and acceptance of the implementation of a pelvic floor muscle training program in SCI inpatient rehabilitation?
3. What are the potential effects of a pelvic floor muscle training program implemented in SCI inpatient rehabilitation on bladder, bowel, and sexual function and quality of life?

Participants will be asked to complete a series of assessments (questionnaires, physical assessments) before and after a 6-week intervention of pelvic floor physical therapy.

## Eligibility

- **Minimum age:** 19 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

1. Are at least 19 years of age.
2. Have a traumatic or non-traumatic SCI
3. Are able to perform a voluntary anal contraction
4. Present with bladder or urinary tract dysfunction from SCI
5. Are a current inpatient at GF Strong Rehabilitation Center and are expected to remain as an inpatient for at least 6 weeks after the time of consent.
6. Are able to speak and understand English.

Exclusion Criteria:

1. Present with symptoms of lower motor neuron injury to the sacral segments (e.g. negative anal and bulbocavernosus reflexes)
2. Present with any other condition besides SCI that impacts the pelvic floor muscles or other pelvic structures
3. Are planning to receive intra-detrusor Botox injections in the next 3 months
4. Have a brain injury or other condition that interferes with their ability to follow instructions
5. Are using a ventilator
6. Have severe and unmanaged spasticity (involuntary muscle tightness or spasms) or contractures (prolonged muscle/joint stiffness)
7. Are unable to tolerate transfers to or lie on a physical therapy table
8. Experience severe pain that interferes with their ability to participate in pelvic floor muscle training
```

## Arms

- **Pelvic Floor Muscle Physical Therapy** (EXPERIMENTAL) — Pelvic floor muscle physical therapy 5/week for 6 weeks.

## Interventions

- **Pelvic Floor Muscle Physiotherapy** (BEHAVIORAL) — Pelvic floor muscle physiotherapy 5x/week for 6-weeks.

## Primary Outcomes

- **Feasibility - Recruitment Rate** _(time frame: Through study completion, an average of 8 months)_ — Recruitment Rate will be evaluated by the number of participants approached, screened for eligibility, and invited to enroll in the study, relative to the number of overall inpatients admitted to the GF Strong Rehabilitation Center SCI unit. We will document the number of participants who enrolled, declined enrollment, or did not respond to our invitation to enroll, as well as the reasons for not enrolling when available.
- **Feasibility - Compliance** _(time frame: Through study completion, an average of 8 months)_ — Compliance will be tracked by the number of participants who underwent the intervention, as well as their adherence to the prescribed exercise program (attendance to supervised sessions and diaries), with reasons for missed sessions or drop-outs noted.
- **Feasibility - Acceptability (Perceived Acceptability Questionnaire)** _(time frame: Through study completion, an average of 8 months)_ — Acceptability of the intervention will be assessed using a study-specific questionnaire, the Perceived Acceptability Questionnaire, developed for this study. The questionnaire aims to capture participants' enjoyment of the PFMT program and their perceptions of its benefits for urinary, bowel, and sexual health. Each item is rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree), with higher scores reflecting greater perceived acceptability and benefit.

## Secondary Outcomes

- **Incontinence Quality of Life Questionnaire (I-QoL)** _(time frame: Through study completion, an average of 8 months)_
- **Neurogenic Bladder Symptoms Score (NBSS)** _(time frame: Through study completion, an average of 8 months)_
- **Timed Bowel Routine** _(time frame: Through study completion, an average of 8 months)_
- **Neurogenic Bowel Dysfunction Score (NBDS)** _(time frame: Through study completion, an average of 8 months)_
- **International Index of Erectile Function (IIEF) Questionnaire** _(time frame: Through study completion, an average of 8 months)_
- **Female Sexual Function Index (FSFI) Questionnaire** _(time frame: Through study completion, an average of 8 months)_
- **Sexual Quality of Life Questionnaire - Male/Female (SQoL)** _(time frame: Through study completion, an average of 8 months)_
- **S4/5 Questionnaire** _(time frame: Through study completion, an average of 8 months)_
- **Pelvic Floor Electromyography** _(time frame: From enrollment to the end of treatment at 6-weeks, or discharge from inpatient care)_
- **Ultrasound Assessment** _(time frame: From enrollment to the end of treatment at 6-weeks, or discharge from inpatient care)_

## Locations (1)

- GF Strong Rehabilitation Centre, Vancouver, British Columbia, Canada — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.gf strong rehabilitation centre|vancouver|british columbia|canada` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT07519928.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT07519928*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*